Brian Paul O'Neill

Title: Brian Paul O'Neill: Innovator in Inhalable Formulations

Introduction

Brian Paul O'Neill is a notable inventor based in Waterford, Ireland. He has made significant contributions to the field of inhalable formulations, particularly with his innovative work involving fluticasone propionate and albuterol sulfate. His expertise and dedication to improving respiratory therapies have positioned him as a key figure in pharmaceutical innovation.

Latest Patents

O'Neill holds a patent for an inhalable formulation that combines fluticasone propionate and albuterol sulfate. This invention relates to a fixed-dose dry powder inhalation formulation that includes an α-lactose monohydrate carrier. In this formulation, albuterol sulfate plays a crucial role in stabilizing fluticasone propionate, enhancing the efficacy of the treatment for respiratory conditions. He has 1 patent to his name.

Career Highlights

Brian Paul O'Neill is currently employed at Norton (Waterford) Limited, where he continues to develop innovative solutions in the pharmaceutical industry. His work focuses on creating effective inhalation therapies that can significantly improve patient outcomes. O'Neill's commitment to research and development has been instrumental in advancing inhalation technology.

Collaborations

Throughout his career, O'Neill has collaborated with talented professionals in the field. Notable coworkers include Chris David Edlin and Hardik Kirtikumar Shah, who have contributed to various projects alongside him. Their combined expertise fosters a collaborative environment that drives innovation.

Conclusion

Brian Paul O'Neill is a distinguished inventor whose work in inhalable formulations has the potential to transform respiratory therapies. His dedication to innovation and collaboration continues to make a significant impact in the pharmaceutical industry.